Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women

Peptides

Volumn 51, Issue , 2014, Pages 86-90

  Li, Xiao Yang ^a   Tang, Shao Hua ^a   Zhou, Xiao Cong ^a   Ye, Ying Hai ^a   Xu, Xue Qin ^a   Li, Ri Zeng ^a  

^a WENZHOU CENTRAL HOSPITAL   (China)

Author keywords

Biomarker; Breast cancer; Prognosis; Visfatin

Indexed keywords

BIOLOGICAL MARKER; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHINESE; CONTROLLED STUDY; DEATH; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MORTALITY; OVERALL SURVIVAL; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SECOND CANCER;

BIOMARKER; BREAST CANCER; PROGNOSIS; VISFATIN;

ADULT; BREAST NEOPLASMS; CHINA; CYTOKINES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84889651033     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.11.010     Document Type: Article

References (19)

1. S.K. Bae, S.R. Kim, J.G. Kim, J.Y. Kim, T.H. Koo, and H.O. Jang Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1 FEBS Lett 580 2006 4105 4113 (Pubitemid 44037574)
2. T.Q. Bi, and X.M. Che Nampt/PBEF/visfatin and cancer Cancer Biol Ther 10 2010 119 125
3. J. Chen, J.F. Weng, W.C. Hong, L.F. Luo, W. Yu, and S.D. Luo Change in plasma visfatin level after severe traumatic brain injury Peptides 38 2012 8 12
4. M. Dalamaga, S. Archondakis, G. Sotiropoulos, K. Karmaniolas, N. Pelekanos, and E. Papadavid Could serum visfatin be a potential biomarker for postmenopausal breast cancer? Maturitas 71 2012 301 308
5. M. Dalamaga, K. Karmaniolas, E. Papadavid, N. Pelekanos, G. Sotiropoulos, and A. Lekka Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters Menopause 18 2011 1198 1204
6. M.A. Folgueira, D.M. Carraro, H. Brentani, D.F. Patrao, E.M. Barbosa, and M.M. Netto Gene expression profile associated with response to doxorubicin-based therapy in breast cancer Clin Cancer Res 11 2005 7434 7443 (Pubitemid 41507704)
7. M. Galli, F. Van Gool, A. Rongvaux, F. Andris, and O. Leo The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer Cancer Res 70 2010 8 11
8. A. Garten, S. Petzold, A. Körner, S.-I. Imai, and W. Kiess Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol Metab 20 2009 130 138
9. R. Gen, E. Akbay, N. Muslu, K. Sezer, and F. Cayan Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance Gynecol Endocrinol 25 2009 241 245
10. W. Hu, C.W. Liu, J. Su, J. Lu, Y. Zhu, and B.W. Liu Elevated plasma visfatin concentrations in patients with community-acquired pneumonia Peptides 43 2013 8 12
11. J.G. Kim, E.O. Kim, B.R. Jeong, Y.J. Min, J.W. Park, and E.S. Kim Visfatin stimulates proliferation of MCF-7 human breast cancer cells Mol Cells 30 2010 341 345
12. Y.C. Lee, Y.H. Yang, J.H. Su, H.L. Chang, M.F. Hou, and S.S.F. Yuan High visfatin expression in breast cancer tissue is associated with poor survival Cancer Epidemiol Biomarkers Prev 20 2011 1892 1901
13. A.R. Moschen, R.R. Gerner, and H. Tilg Pre-B cell colony enhancing factor/Nampt/visfatin in iniflammation and obesity-related disorders Curr Pharm Des 16 2010 1913 1920
14. T.E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Gotoda, and H. Katai Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer J Gastroenterol 44 2009 685 690
15. V.G. Vogel Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer Menopause 15 2008 782 789
16. B. Wang, M.K. Hasan, E. Alvarado, H. Yuan, H. Wu, and W.Y. Chen NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response Oncogene 30 2011 907 921
17. T. Yonezawa, S. Haga, Y. Kobayashi, T. Takahashi, and Y. Obara Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway FEBS Lett 580 2006 6635 6643 (Pubitemid 44827021)
18. D.R. Youlden, S.M. Cramb, N.A. Dunn, J.M. Muller, C.M. Pyke, and P.D. Baade The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality Cancer Epidemiol 36 2012 237 248
19. L.Q. Zhang, D.P. Heruth, and S.Q. Ye Nicotinamide phosphoribosyltransferase in human diseases J Bioanal Biomed 3 2011 13 25